SIGLEC1 and psoriasis: Interestingly, approximately 18% of CD169+ skin macrophages were tdTomato+ on day 5 after IMQ treatment, proving that monocytes contribute to the increased CD169+ skin macrophage pool during psoriasis development (Figure 2G).